SynthesisBMC endocrine disorders2026
Altered cortical thickness in type 2 diabetes mellitus patients revealed by coordinate-based meta-analysis.
Synthesis in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundType 2 diabetes mellitus (T2DM) is associated with an increased risk of cognitive decline and neurodegenerative changes. Understanding structural brain changes in T2DM patients is crucial for developing targeted interventions.
methodsThis study adheres to the PRISMA guidelines and is registered on PROSPERO (CRD420251056572). Coordinate-based meta-analysis (CBMA) was used via seed-based d-mapping (SDM) technique to analyze cortical thickness (CTh) variations between T2DM patients and healthy controls (HC). Data were retrieved from PubMed and Web of Science up to April 30, 2025, using pre-specified inclusion and exclusion criteria.
resultsSignificant CTh reductions were detected in the right rolandic operculum (ROL) and left superior temporal gyrus (STG) in T2DM patients. Jackknife analyses confirmed the robustness of these findings. Meta-regression suggested a negative association between BMI and CTh in these two regions, indicating that elevated BMI is associated with more pronounced cortical thinning.
conclusionOur study highlights specific brain regions impacted by T2DM, suggesting that neurodegenerative mechanisms and clinical correlates are involved. These findings highlight the necessity for integrated metabolic and neurological strategies for T2DM management. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.